Evidence map›Paper›PMID 25807013›Full record

ArticlePloS one2015

Crystal structures of the kinase domain of the sulfate-activating complex in Mycobacterium tuberculosis.

Ömer Poyraz, Katharina Brunner, Bernhard Lohkamp, Hanna Axelsson, Lars G J Hammarström, Robert Schnell, Gunter Schneider

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Mechanism of Mongolian Medicine Batri-7 onJournal of inflammation research · 2025
    Article
  3. CysB Is a Key Regulator of the Antifungal Activity ofInternational journal of molecular sciences · 2023
    Article
  4. Article
  5. Commonalities ofFrontiers in immunology · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ömer PoyrazDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Katharina BrunnerDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Bernhard LohkampDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Hanna AxelssonChemical Biology Consortium Sweden, Science for Life Laboratory Stockholm, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Lars G J HammarströmChemical Biology Consortium Sweden, Science for Life Laboratory Stockholm, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Robert SchnellDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Gunter SchneiderDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Karolinska Institutet · SEScience for Life Laboratory · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Mycobacterium tuberculosis the sulfate activating complex provides a key branching point in sulfate assimilation. The complex consists of two polypeptide chains, CysD and CysN. CysD is an ATP sulfurylase that, with the energy provided by the GTPase activity of CysN, forms adenosine-5'-phosphosulfate (APS) which can then enter the reductive branch of sulfate assimilation leading to the biosynthesis of cysteine. The CysN polypeptide chain also contains an APS kinase domain (CysC) that phosphorylates APS leading to 3'-phosphoadenosine-5'-phosphosulfate, the sulfate donor in the synthesis of sulfolipids. We have determined the crystal structures of CysC from M. tuberculosis as a binary complex with ADP, and as ternary complexes with ADP and APS and the ATP mimic AMP-PNP and APS, respectively, to resolutions of 1.5 Å, 2.1 Å and 1.7 Å, respectively. CysC shows the typical APS kinase fold, and the structures provide comprehensive views of the catalytic machinery, conserved in this enzyme family. Comparison to the structure of the human homolog show highly conserved APS and ATP binding sites, questioning the feasibility of the design of specific inhibitors of mycobacterial CysC. Residue Cys556 is part of the flexible lid region that closes off the active site upon substrate binding. Mutational analysis revealed this residue as one of the determinants controlling lid closure and hence binding of the nucleotide substrate.

Indexed as

Adenosine PhosphosulfateAdenosine TriphosphateAmino Acid SequenceCatalytic DomainMolecular Sequence DataMycobacterium tuberculosisNucleotidesPeptidesPhosphoadenosine PhosphosulfatePhosphotransferases (Alcohol Group Acceptor)Protein Structure, TertiarySequence AlignmentSulfate AdenylyltransferaseSulfatesAdenosine PhosphosulfateAdenosine Triphosphateadenylylsulfate kinaseNucleotidesPeptidesPhosphoadenosine PhosphosulfatePhosphotransferases (Alcohol Group Acceptor)Sulfate AdenylyltransferaseSulfates

Identifiers

PMID25807013
PMCPMC4373884
OpenAlexW2095519418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.